K2M Group Holdings Inc. (KTWO) Trading Down 0.8%
K2M Group Holdings Inc. (NASDAQ:KTWO)’s share price traded down 0.8% during trading on Friday . The stock traded as low as $15.85 and last traded at $15.91, with a volume of 65,780 shares changing hands. The stock had previously closed at $16.04.
Several equities analysts have commented on the stock. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $23.00 target price on shares of K2M Group Holdings in a research note on Friday, August 5th. JMP Securities restated a “buy” rating and set a $22.00 price objective on shares of K2M Group Holdings in a research report on Sunday, June 5th. Needham & Company LLC restated a “strong-buy” rating and set a $22.00 price objective (up previously from $21.00) on shares of K2M Group Holdings in a research report on Friday, August 5th. Piper Jaffray Cos. restated an “overweight” rating and set a $22.00 price objective on shares of K2M Group Holdings in a research report on Friday, May 20th. Finally, Barclays PLC raised their price objective on shares of K2M Group Holdings from $20.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, August 4th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. K2M Group Holdings has an average rating of “Buy” and a consensus price target of $22.20.
The company has a 50-day moving average of $16.72 and a 200 day moving average of $14.67. The stock’s market capitalization is $674.32 million.
K2M Group Holdings (NASDAQ:KTWO) last issued its earnings results on Wednesday, August 3rd. The medical device company reported ($0.27) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.28) by $0.01. The firm earned $59.20 million during the quarter, compared to analyst estimates of $57.47 million. The firm’s revenue for the quarter was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.16) EPS. On average, equities analysts predict that K2M Group Holdings Inc. will post ($1.10) EPS for the current year.
K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine technologies and techniques. The Company’s spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. The Company is engaged in designing, development and commercialization of products for patients suffering from degenerative spinal conditions.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.